Volume: 3 Issue: 2
Year: 2015, Page: 18-20,
Objective: Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma, characterized by skin-homing of clonal, mature malignant T-lymphocytes. MF develops slowly over several years and may have a variety of clinical presentations. In addition to the classical clinical lesions-itchy patches, plaques or tumors, it may also present with atypical hypopigmented lesions, dermatophytic lesions or psoriasiform lesions that may be confused with common benign conditions such as eczema and psoriasis.
Clinical picture may pose a significant challenge and a diagnostic dilemma to the dermatologist. Longterm follow up and serial biopsies help to establish definitive diagnosis.
Keywords: Mycosis fungoides (MF), Cutaneous lymphoma, Psoriasis, Vitiligo.
1. Whittaker SJ, Foss FM. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma. Cancer Treat Rev. 2007;33:146–160.
2. Scarisbrick JJ. Staging and management of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2006;31:181–186.
3. Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sézary syndrome. Lancet. 2008;371:945– 957.
4. Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol. 2007;156:1–10.
5. Smoller BR. Mycosis fungoides: what do/do not we know? J Cutan Pathol. 2008;35(suppl 2):35–39.
6. Kim-James HY, Heffernan MP. The diagnosis, evaluation, and treatment of cutaneous T-cell lymphoma. Curr Probl Dermatol. 2001;13:307–340.
7. Zinzani PL, Ferreri AJ, Cerroni L. Mycosis fungoides. Crit Rev Oncol Hematol. 2008;65:172–182.
8. Ryan EA,Sanderson KV, Bartak P,Samman PD.Can mycosis fungoides begin in the epidermis?A hypothesis.Br J Dermatol 1973;88:419-29.
Swetha D,Pratap D V S. Mycosis fungoides: A Chameleon of Dermatology.Perspectives in medical research 2015;3:2:18-20.